![](/img/cover-not-exists.png)
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Chen, WVolume:
13
Language:
english
Journal:
Value in Health
DOI:
10.1016/S1098-3015(11)72842-X
Date:
November, 2010
File:
PDF, 76 KB
english, 2010